Related Experiment Video
Updated: Jul 26, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Circulating leptin and body composition in chronic obstructive pulmonary disease.
S Karakas1, F Karadag, A B Karul
1Department of Anatomy, School of Medicine, Adnan Menderes University, Aydin, Turkey.
In chronic obstructive pulmonary disease (COPD), circulating leptin levels do not increase with weight loss. Leptin is actually lower in COPD patients with low body mass index (BMI), suggesting a compensatory mechanism.
Area of Science:
- Endocrinology
- Pulmonology
- Nutritional Science
Background:
- Nutritional depletion and weight loss are common in chronic obstructive pulmonary disease (COPD), impacting patient prognosis.
- The exact mechanisms driving weight loss in COPD remain incompletely understood.
- Leptin, a hormone regulating energy balance, is a potential factor in COPD-related weight changes.
Purpose of the Study:
- To investigate the association between serum leptin levels and body composition in male COPD outpatients.
- To compare leptin concentrations between COPD patients with varying body mass index (BMI) and healthy controls.
Main Methods:
- Thirty male COPD outpatients and 20 healthy male controls were enrolled.
- Standard spirometry and body composition measurements were performed.
- Serum leptin concentration was quantified using ELISA, and patients were grouped by BMI.
Main Results:
- COPD patients with low BMI (mean 19.01 kg/m2) exhibited lower mean leptin levels (1.41 ng/ml) compared to those with normal/high BMI (2.60 ng/ml) and controls (2.82 ng/ml).
- Leptin levels significantly correlated with BMI, body weight, waist circumference, skinfold thickness, and body fat percentage (p < 0.05).
- Circulating leptin did not increase with weight loss in COPD patients.
Conclusions:
- Increased circulating leptin is unlikely to be the primary cause of weight loss in COPD.
- Leptin levels appear regulated in COPD and may decrease in underweight patients, potentially as a mechanism to conserve body fat.
- Further research is warranted to elucidate the role of leptin in COPD pathophysiology and weight management.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
05:45Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
Published on: October 25, 2019
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations